Can Vaccine Storage Flexibility Support a Faster Vaccine Rollout in Switzerland
According to new stability evidence assessed by Swissmedic, (the Swiss surveillance authority for medicines and medical devices) the COVID-19 vaccine from Pfizer/BioNTech efficacy can be assured for up to two weeks when stored at -25 to -15 degrees Celsius (freezer temperature). This is a critical factor for the Swiss vaccine rollout programme, enabling the vaccines to be available in health centres, medical practices and pharmacies throughout Switzerland. This increase in the elasticity and adaptability of the distribution as well as...
View full press release